LIKE many cancers, ovarian cancer has long been known as a ‘silent’ disease. This is because its symptoms tend to be vague, ...

The comparable rates of remission pre- and post-pandemic suggest that COVID-19 did not negatively impact the outcomes of ...

The World Ovarian Cancer Coalition (the Coalition) announced today the publication of a first-of-its-kind study that reveals ...

Ovarian cancer has historically been called a “ silent killer ,” because clinicians thought its symptoms were undetectable. Patients were often diagnosed so late that doctors thought nothing could be ...

Clinical trials of a simple and accurate blood test to detect early-stage ovarian cancer – key to boosting survival rates – ...

Ovarian cancer is one of the deadliest gynaecological cancers, yet there currently is no early diagnostic test. Here’s what you need to know.

Clinical trials of a simple and accurate blood test to detect early-stage ovarian cancer - key to boosting survival rates - ...

Screening for risk factors of ovarian cancer using artificial intelligence, UniSA researchers found that the oral ...

Queensland women are to take part in groundbreaking clinical trials for a blood test that will detect early stage ovarian cancer.

Results from OVATION 2 Study continue to validate TheraPlas® technology, demonstrating DNA-mediated production of key anti-cancer immune cytokines following treatment IMNN-001 continues to show ...